|
China's Gastric Cancer Drug Market to Nearly Triple by 2012: A Promising Market for Targeted Therapies
— A Webinar from Decision Resources
Based on our recent Emerging Markets report, Gastric Cancer in China, Decision Resources is offering an exclusive, in-depth webinar entitled China’s Gastric Cancer Drug Market to Nearly Triple by 2012: A Promising Market for Targeted Therapies. Because this webinar will feature major report findings, it is only available to purchasers of this Emerging Markets report.
This exclusive in-depth webinar will be presented by the author of the report, Decision Resources analyst Victor Li, Ph.D. Dr. Li will answer the following questions:
- The incidence of gastric cancer (CaG) in China is among the highest in the world. What are the major risk factors and their changing trends in China for CaG?
- How are physicians treating CaG in China? What are the most common modalities for each stage?
- What is the most common chemotherapy regimen for CaG treatment in China? What are the preferred targeted therapies in key regions of China?
- What are the current status and future trend of pricing and reimbursement for CaG therapies? How is the market affected?
Dr. Li will be available to answer questions after the presentation.
This event will be held:
April 24th at 10 a.m. U.S. Eastern Time, 4 p.m. Central European Time (Paris).
To learn how you can purchase the Emerging Markets report entitled Gastric Cancer in China and attend this webinar, please contact:
In North America — Steve Silvestro at 781-296-2626 or ssilvestro@dresources.com
In Europe — Kaj van Langendonck at +32-2-357-06-14 or kvanlangendonck@decisionresources.be
In Japan — Makiko Yoshimoto at +81-3-5401-2615 or makiko@dresources.jp
|
